FDAFDA · Food and drugs·Recall number D-0322-2024
Nortrel 7/7/7 (norethindrone and ethinyl estradiol tablets USP- triphasic regimen), packaged in cartons, each carton contains 6 blister cards, each card contains 28 tablets, Rx only, TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC 0555-9012-58
Published February 21, 2024 · Recall initiated: January 25, 2024
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- NORTREL 7/7/7
- Manufacturer
- Teva Pharmaceuticals USA, Inc
- Distributor
- nationwide
- Lot
- Lot #: 100040731, Exp 7/31/2024
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.